Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001027779 | SCV001053215 | likely benign | Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV001027779 | SCV001190386 | uncertain significance | Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative | 2021-03-30 | criteria provided, single submitter | clinical testing | CYBA NM_000101.3 exon 4 p.Val76Met (c.226G>A): This variant has been reported in the literature in 1 individual with inflammatory bowel disease (Denson 2018 PMID:29454792) and is present in 0.8% (205/24936) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-88713224-C-T). Evolutionary conservation for this variant is limited or unavailable; computational predictive tools for this variant suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Gene |
RCV004797886 | SCV005419457 | uncertain significance | not provided | 2024-05-30 | criteria provided, single submitter | clinical testing | Reported in published literature in association with inflammatory bowel disease in an individual who also harbored variants other genes (PMID: 29454792); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29454792) |
Natera, |
RCV001277895 | SCV001464874 | likely benign | Chronic granulomatous disease | 2020-10-13 | no assertion criteria provided | clinical testing |